|
The Effectiveness, cost-effectiveness and acceptability of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual randomised balanced incomplete block trial |
Reeves BC, Scott LJ, Taylor J, Hogg R, Rogers CA, Wordsworth S, Townsend D, Muldrew A, Peto T, Violato M, Dakin H, Cappel-Porter H, Mills N, O'Reilly |
|
|
Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Reeves BC, Scott LJ, Taylor J, Hogg R, Rogers CA, Wordsworth S, Townsend D, Muldrew A, Peto T, Violato M, Dakin H, Cappel-Porter H, Mills N, O'Reilly. The Effectiveness, cost-effectiveness and acceptability of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual randomised balanced incomplete block trial. Health Technology Assessment 2016; 20(80) Authors' objectives To compare the proportion of correct lesion classifications made by community-based optometrists and ophthalmologists from vignettes of patients; to estimate the cost-effectiveness of community follow-up by optometrists compared with follow-up by ophthalmologists in the Hospital Eye Service (HES); to ascertain views of patients, their representatives, optometrists, ophthalmologists and clinical commissioners on the proposed shared care model.
Patients with neovascular age-related macular degeneration (nAMD) usually attend regular reviews, even when the disease is quiescent. Reviews are burdensome to health services, patients and carers. Authors' conclusions The ability of optometrists to make nAMD retreatment decisions from vignettes is non-inferior to that of ophthalmologists. Various barriers to implementing shared cared for nAMD were identified. Indexing Status Subject indexing assigned by CRD MeSH Community Health Services; Eye Diseasess; Macular Degeneration; Outpatient Clinics, Hospital Language Published English Country of organisation England English summary An English language summary is available. Address for correspondence NETSCC, Health Technology Assessment, Alpha House, University of Southampton Science Park, Southampton, SO16 7NS UK Tel: +44 23 8059 5586 Email: hta@hta.ac.uk AccessionNumber 32013000975 Date abstract record published 17/12/2013 |
|
|
|